Practice Variation in Prescribing SGLT2-Inhibitors: A Population-Based Analysis from Alberta, Canada
The rate of new SGLT2i prescriptions was low during the study period. Both patient- and prescriber-level factors are associated with SGLT2i prescription, although variation in prescribing SGLT2i medications appears to be driven primarily by prescriber factors. Family physicians are responsible for the majority of SGLT2i prescriptions and represent a key provider group in aligning SGLT2i prescribing with guideline recommendations.
Authors
- Braden Manns (ORCID: https://orcid.org/0000-0002-8823-6127)
- Derek S. Chew (ORCID: https://orcid.org/0000-0003-3539-7485)
- Paul E. Ronksley (ORCID: https://orcid.org/0000-0002-3958-7561)
- Darren Lau (ORCID: https://orcid.org/0000-0001-9923-7902)
- Rahim Kanji (ORCID: https://orcid.org/0000-0002-9801-259X)
- Flora Au (ORCID: https://orcid.org/0000-0001-5189-8488)
- Reed F. Beall (ORCID: https://orcid.org/0000-0001-8188-7616)
- Amity E. Quinn (ORCID: https://orcid.org/0000-0002-1327-310X)
- David J. Campbell
Institutions
- Alberta Health Services (CA)
- University of Alberta (CA)
- University of Calgary (CA)
- Calgary Laboratory Services (CA)
- Libin Cardiovascular Institute of Alberta (CA)
Publication Details
- Journal
- CJC Open
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1016/j.cjco.2025.11.015
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Government of Alberta